Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease

医学 科克伦图书馆 弱点 梅德林 物理疗法 奇纳 心理信息 物理医学与康复 肌肉无力 系统回顾 神经肌肉疾病 生活质量(医疗保健) 随机对照试验 疾病 心理干预 内科学 外科 护理部 法学 政治学
作者
Sarah E. Jones,William D‐C Man,Wei Gao,Irene J Higginson,Andrew Wilcock,Matthew Maddocks
出处
期刊:The Cochrane library [Elsevier]
卷期号:2016 (10) 被引量:188
标识
DOI:10.1002/14651858.cd009419.pub3
摘要

Background This review is an update of a previously published review in the Cochrane Database of Systematic Reviews Issue 1, 2013 on Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Patients with advanced progressive disease often experience muscle weakness, which can impact adversely on their ability to be independent and their quality of life. In those patients who are unable or unwilling to undertake whole‐body exercise, neuromuscular electrical stimulation (NMES) may be an alternative treatment to enhance lower limb muscle strength. Programmes of NMES appear to be acceptable to patients and have led to improvements in muscle function, exercise capacity, and quality of life. However, estimates regarding the effectiveness of NMES based on individual studies lack power and precision. Objectives Primary objective: to evaluate the effectiveness of NMES on quadriceps muscle strength in adults with advanced disease. Secondary objectives: to examine the safety and acceptability of NMES, and its effect on peripheral muscle function (strength or endurance), muscle mass, exercise capacity, breathlessness, and health‐related quality of life. Search methods We identified studies from searches of the Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews (CDSR), and Database of Abstracts of Reviews of Effects (DARE) (the Cochrane Library), MEDLINE (OVID), Embase (OVID), CINAHL (EBSCO), and PsycINFO (OVID) databases to January 2016; citation searches, conference proceedings, and previous systematic reviews. Selection criteria We included randomised controlled trials in adults with advanced chronic respiratory disease, chronic heart failure, cancer, or HIV/AIDS comparing a programme of NMES as a sole or adjunct intervention to no treatment, placebo NMES, or an active control. We imposed no language restriction. Data collection and analysis Two review authors independently extracted data on study design, participants, interventions, and outcomes. We assessed risk of bias using the Cochrane 'Risk of bias' tool. We calculated mean differences (MD) or standardised mean differences (SMD) between intervention and control groups for outcomes with sufficient data; for other outcomes we described findings from individual studies. We assessed the evidence using GRADE and created a 'Summary of findings' table. Main results Eighteen studies (20 reports) involving a total of 933 participants with COPD, chronic respiratory disease, chronic heart failure, and/or thoracic cancer met the inclusion criteria for this update, an additional seven studies since the previous version of this review. All but one study that compared NMES to resistance training compared a programme of NMES to no treatment or placebo NMES. Most studies were conducted in a single centre and had a risk of bias arising from a lack of participant or assessor blinding and small study size. The quality of the evidence using GRADE comparing NMES to control was low for quadriceps muscle strength, moderate for occurrence of adverse events, and very low to low for all other secondary outcomes. We downgraded the quality of evidence ratings predominantly due to inconsistency among study findings and imprecision regarding estimates of effect. The included studies reported no serious adverse events and a low incidence of muscle soreness following NMES. NMES led to a statistically significant improvement in quadriceps muscle strength as compared to the control (12 studies; 781 participants; SMD 0.53, 95% confidence interval (CI) 0.19 to 0.87), equating to a difference of approximately 1.1 kg. An increase in muscle mass was also observed following NMES, though the observable effect appeared dependent on the assessment modality used (eight studies, 314 participants). Across tests of exercise performance, mean differences compared to control were statistically significant for the 6‐minute walk test (seven studies; 317 participants; 35 m, 95% CI 14 to 56), but not for the incremental shuttle walk test (three studies; 434 participants; 9 m, 95% CI ‐35 to 52), endurance shuttle walk test (four studies; 452 participants; 64 m, 95% CI ‐18 to 146), or for cardiopulmonary exercise testing with cycle ergometry (six studies; 141 participants; 45 mL/minute, 95% CI ‐7 to 97). Limited data were available for other secondary outcomes, and we could not determine the most beneficial type of NMES programme. Authors' conclusions The overall conclusions have not changed from the last publication of this review, although we have included more data, new analyses, and an assessment of the quality of the evidence using the GRADE approach. NMES may be an effective treatment for muscle weakness in adults with advanced progressive disease, and could be considered as an exercise treatment for use within rehabilitation programmes. Further research is very likely to have an important impact on our confidence in the estimate of effect and may change the estimate. We recommend further research to understand the role of NMES as a component of, and in relation to, existing rehabilitation approaches. For example, studies may consider examining NMES as an adjuvant treatment to enhance the strengthening effect of programmes, or support patients with muscle weakness who have difficulty engaging with existing services.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lelelele完成签到,获得积分10
1秒前
1秒前
Jay完成签到,获得积分10
2秒前
FashionBoy应助笑点低诗桃采纳,获得10
3秒前
3秒前
青柠完成签到,获得积分10
4秒前
258369发布了新的文献求助10
6秒前
Ava应助俏皮的白柏采纳,获得10
7秒前
James- LPY发布了新的文献求助10
8秒前
千余发布了新的文献求助10
11秒前
anan完成签到,获得积分10
11秒前
14秒前
14秒前
15秒前
16秒前
莹0000完成签到,获得积分10
17秒前
18秒前
YamDaamCaa应助科研通管家采纳,获得30
19秒前
YamDaamCaa应助科研通管家采纳,获得30
20秒前
桐桐应助科研通管家采纳,获得10
20秒前
20秒前
烟花应助科研通管家采纳,获得10
20秒前
星辰大海应助科研通管家采纳,获得10
20秒前
20秒前
moon发布了新的文献求助10
20秒前
幽默尔蓝发布了新的文献求助10
20秒前
默默的裘完成签到,获得积分10
22秒前
科研通AI2S应助liuzengzhang666采纳,获得10
23秒前
深情安青应助lll采纳,获得10
24秒前
闪闪完成签到,获得积分10
25秒前
AST灰烬发布了新的文献求助10
25秒前
26秒前
鲤跃发布了新的文献求助10
28秒前
29秒前
30秒前
情怀应助moon采纳,获得10
30秒前
30秒前
lll应助文件撤销了驳回
33秒前
33秒前
陈七七完成签到 ,获得积分10
34秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988868
求助须知:如何正确求助?哪些是违规求助? 3531255
关于积分的说明 11253071
捐赠科研通 3269858
什么是DOI,文献DOI怎么找? 1804822
邀请新用户注册赠送积分活动 881994
科研通“疑难数据库(出版商)”最低求助积分说明 809035